Physician Locator

Get in Touch Find a Physician

Find a Trained Physician

Physicians trained in using the TAMP therapy platform can help determine whether this approach may be appropriate for your care.

RenovoRx Advances TAMP™ into Borderline Resectable Pancreatic Cancer with First Patient Enrolled in Investigator-Initiated PRISM-TAMP Trial

  • Read More

RenovoRx Announces Peer-Reviewed Publication Highlighting the TAMP™ Platform’s Potential to Improve Chemotherapeutic Delivery for Locally Advanced Pancreatic Cancer

  • Read More

TAMP-Mediated Gemcitabine Lowers Systemic Exposure vs IV Delivery in Locally Advanced Pancreatic Cancer

  • Read More

RenovoRx Reports Record Second Quarter 2026 Results, Driven by Accelerating Commercial Adoption and 61% Sequential Quarterly Revenue Growth

  • Read More

RenovoRx Achieves Major Milestone with Full Enrollment in Phase III TIGeR-PaC Trial for Locally Advanced Pancreatic Cancer

  • Read More

RenovoRx Announces First Commercial Clinical Use of RenovoCath® in Sarcoma Patient Treatment, Marking Expansion of Targeted Drug-Delivery Device to Other Solid Tumors

  • Read More

RenovoRx to Highlight TAMP™ Platform at JonesTrading Virtual Key Opinion Leader Webinar on the Evolving Pancreatic Cancer Landscape, August 13th

  • Read More

Winship Offers TAMP™ Therapy Platform for Locally Advanced Pancreatic Cancer

  • Read More

RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET

  • Read More